Published in @kireports.bsky.social this week!
UK multicentre study of kidney transplant recipients shows high recurrence and adverse outcomes after 1st CSCC, with substantial practice variation - supporting the need for evidence-based interventions.
Read at: www.kireports.org/article/S246...
kireports.org
Clinical Equipoise and Unimproved Outcomes following Post-Transplant Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma (CSCC) is the most common malignancy following solid organ transplantation. Historical data suggest that 25% of kidney transplant recipients develop additional CSCC within a year of their first lesion, with significantly increased risks of metastasis and mortality. However, contemporary outcomes and optimal secondary prevention strategies remain unclear.
